Open Now
Contact Information
721 South Fawcett Avenue Suite 201, Tacoma, Washington 98402, United States
Detailed Information
Metropolitan Development Council The Center
-
Services:
- Smoking permitted without restriction
- Outcome follow-up after discharge
- Naloxone and overdose education
- Aftercare/continuing care
- Vaping permitted without restriction
- Early intervention for HIV
- Mental health services
- Case management service
- Transportation assistance
- Social skills development
- Comprehensive substance use assessment
- Screening for tobacco use
- Screening for mental disorders
- Screening for substance use
- Comprehensive mental health assessment
- Interim services for clients
- Outreach to persons in the community
- Drug or alcohol urine screening
- Health education services other than HIV/AIDS or hepatitis
- Group counseling
- Smoking/vaping/tobacco cessation counseling
- Individual counseling
- Substance use disorder education
- HIV or AIDS education, counseling, or support
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Telemedicine/telehealth therapy
- Substance use disorder counseling
- Relapse prevention
- Substance use treatment
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Male
- Female
- Outpatient
- Outpatient day treatment or partial hospitalization
- Intensive outpatient treatment
- Regular outpatient treatment
- Employment counseling or training
- Housing services
- Assistance with obtaining social services
- Recovery coach
- Mentoring/peer support
- Other contracted prescribing entity
- Medicaid
- Cash or self-payment
- State-financed health insurance plan other than Medicaid
- Private health insurance
- Federal, or any government funding for substance use treatment programs
- Clonidine
- Medication for mental disorders
- Buprenorphine without naloxone
- Buprenorphine sub-dermal implant
- Buprenorphine with naloxone
- Non-nicotine smoking/tobacco cessation
- Naltrexone (extended-release, injectable)
- Buprenorphine (extended-release, injectable)
- Naltrexone (oral)
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
- Adult women
- Clients with co-occurring mental and substance use disorders
- Clients who have experienced trauma
- Adult men
- Young adults
- Seniors or older adults
- Criminal justice (other than DUI/DWI)/Forensic clients
- Adults
- Young Adults
- State department of health
- Federally Qualified Health Center
- Relapse prevention with naltrexone
- Prescribes buprenorphine
- Private non-profit organization
Facility Smoking Policy
Transitional Services
Facility Vaping Policy
Ancillary Services
Assessment/Pre-treatment
Testing
Education and Counseling Services
Opioid Medications used in Treatment
Treatment Approaches
Type of Care
Gender Accepted
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Recovery Support Services
External Source of Medications Used for Alcohol Use Disorder Treatment
Payment/Insurance/Funding Accepted
Pharmacotherapies
Type of Alcohol Use Disorder Treatment
Special Programs/Groups Offered
Age Groups Accepted
License/Certification/Accreditation
Type of Opioid Treatment
Facility Operation (e.g., Private, Public)
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm